Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition

Brain Research

Volumn 1354, Issue , 2010, Pages 172-178

  Kidd, Sarah K ^a   Schneider, Jay S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dopamine; HDACI (histone deacetylase inhibitor); MPP+; SAHA; Sodium butyrate; Valproate

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BUTYRIC ACID; HISTONE DEACETYLASE; VALPROIC ACID; VORINOSTAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN PROTECTION; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

1-METHYL-4-PHENYLPYRIDINIUM; ACETYLATION; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BUTYRIC ACID; CELL LINE; CELLS, CULTURED; DOPAMINE; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEURONS; RATS; VALPROIC ACID;

ANIMALIA; RATTUS;

EID: 77956414742     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.07.041     Document Type: Article

References (32)

1. P. Anglade, S. Vyas, F. Javoy-Agid, M.T. Herrero, P.P. Michel, J. Marquez, A. Mouatt-Prigent, M. Ruberg, E.C. Hirsch, and Y. Agid Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease Histol. Histopathol. 12 1997 25 31
2. P.S. Chen, G.S. Peng, G. Li, S. Yang, X. Wu, C.C. Wang, B. Wilson, R.B. Lu, P.W. Gean, D.M. Chuang, and J.S. Hong Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes Mol. Psychiatry 11 2006 1116 1125
3. P.S. Chen, C.C. Wang, C.D. Bortner, G.S. Peng, X. Wu, H. Pang, R.B. Lu, P.W. Gean, D.M. Chuang, and J.S. Hong Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity Neuroscience 149 2007 203 212
4. J. Chetsawang, P. Govitrapong, and B. Chetsawang Melatonin inhibits MPP + -induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells J. Pineal Res. 43 2007 115 120
5. J.P. Dompierre, J.D. Godin, B.C. Charrin, F.P. Cordelieres, S.J. King, S. Humbert, and F. Saudou Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation J. Neurosci. 27 2007 3571 3583
6. G. Faraco, T. Pancani, L. Formentini, P. Mascagni, G. Fossati, F. Leoni, F. Moroni, and A. Chiarugi Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain Mol. Pharmacol. 70 2006 1876 1884
7. M. Haberland, R.L. Montgomery, and E.N. Olson The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat. Rev. Genet. 10 2009 32 42
8. E.C. Hirsch, T. Breidert, E. Rousselet, S. Hunot, A. Hartmann, and P.P. Michel The role of glial reaction and inflammation in Parkinson's disease Ann. NY Acad. Sci. 991 2003 214 228
9. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 Suppl 3 2003 S26 S36 discussion S36-8
10. A.G. Kazantsev, and L.M. Thompson Therapeutic application of histone deacetylase inhibitors for central nervous system disorders Nat. Rev. Drug Discov. 7 2008 854 868
11. H.J. Kim, M. Rowe, M. Ren, J.-S. Hong, P.-S. Chen, and D.-M. Chuang Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action J. Pharmacol. Exp. Ther. 321 2007 892 901
12. P. Klivenyi, D. St. Clair, M. Wermer, H.-C. Yen, T. Oberley, L. Yang, and M.F. Beal Manganese superoxide dismutase overexpression attenuates MPTP toxicity Neurobiol. Dis. 5 1998 253 258
13. B. Langley, M.A. D'Annibale, K. Suh, I. Ayoub, A. Tolhurst, B. Bastan, L. Yang, B. Ko, M. Fisher, S. Cho, M.F. Beal, and R.R. Ratan Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection J. Neurosci. 28 2008 163 176
14. +)-induced apoptosis independent of MAO-B inhibition Neurosci Lett. 224 1997 197 200
15. Y. Leng, M.H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.M. Chuang Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition J. Neurosci. 28 2008 2576 2588
16. H. Mochizuki, N. Nakamura, K. Nishi, and Y. Mizuno Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat Neurosci. Lett. 170 1994 191 194
17. H. Mochizuki, K. Goto, H. Mori, and Y. Mizuno Histochemical detection of apoptosis in Parkinson's disease J. Neurol. Sci. 137 1996 120 123
18. J.M.A. Oliveira, S. Chen, S. Almeida, R. Riley, J. Goncalves, C.R. Oliveira, M.R. Hayden, D.G. Nicholls, L.M. Ellerby, and A.C. Rego Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors J. Neurosci. 26 2006 11174 11186
19. G.S. Peng, G. Li, N.S. Tzeng, P.S. Chen, D.M. Chuang, Y.D. Hsu, S. Yang, and J.S. Hong Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia Brain Res. Mol. Brain Res. 134 2005 162 169
20. S. Petri, M. Kiaei, K. Kipiani, J. Chen, N.Y. Calingasan, J.P. Crow, and M.F. Beal Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis Neurobiol. Dis. 22 2006 40 49
21. C.J. Phiel, F. Zhang, E.Y. Huang, M.G. Guenther, M.A. Lazar, and P.S. Klein Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J. Biol. Chem. 276 2001 36734 36741
22. S. Przedborski, and V. Jackson-Lewis Mechanisms of MPTP toxicity Mov. Disord. 13 Suppl 1 1998 35 38
23. S.W. Remiszewski Recent advances in the discovery of small molecule histone deacetylase inhibitors Curr Opin Drug Discov Devel. 5 2002 487 499
24. M.G. Riggs, R.G. Whittaker, J.R. Neumann, and V.M. Ingram n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells Nature 268 1977 462 464
25. C. Rouaux, N. Jokic, C. Mbebi, S. Boutillier, J.P. Loeffler, and A.L. Boutillier Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration EMBO J. 22 2003 6537 6549
26. H. Ryu, J. Lee, B.A. Olofsson, A. Mwidau, A. Dedeoglu, M. Escudero, E. Flemington, J. Azizkhan-Clifford, R.J. Ferrante, and R.R. Ratan Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway Proc. Natl Acad. Sci. USA 100 2003 4281 4286
27. F.A. Schroeder, C.L. Lin, W.E. Crusio, and S. Akbarian Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse Biol. Psychiatry 62 2007 55 64
28. +)-induced apoptosis in SK-N-SH neurons J. Neurocytol. 32 2003 329 343
29. S.G. Speciale MPTP: insights into parkinsonian neurodegeneration Neurotoxicol. Teratol. 24 2002 607 620
30. N.A. Tatton, and S.J. Kish In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience 77 1997 1037 1048
31. Y. Wang, X. Wang, and L. Liu HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells Neurosci. Lett. 467 2009 212 216
32. X. Wu, P.S. Chen, S. Dallas, B. Wilson, M.L. Block, C.C. Wang, H. Kinyamu, N. Lu, X. Gao, Y. Leng, D.M. Chuang, W. Zhang, R.B. Lu, and J.S. Hong Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons Int. J. Neuropsychopharmacol. 2008 1 12